Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-09-24FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original application for clobetasol propionate topical (generic) by Zydus Lifesciences Limited, adding another generic opti…
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE EMOLLIENT FORMULATION — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for a clobetasol propionate emollient formulation from Padagis Israel Pharmaceuticals Ltd, granting …
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries, enhancing its approval under the gener…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Human Repeated Insult Patch Test [NA]
Completed human repeated insult patch test study by NeXtGen Biologics for dermatitis/allergy conditions; results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-02-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's generic clobetasol propionate topical product under an Original Application (ANDA).
-
FDA approval · 2019-02-13FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals' generic fluocinonide acetonide topical solution 0.01% (Original Application) for inflammatory and pruritic cor…
-
FDA approval · 2019-01-30FDA Approved: DESONIDE OINTMENT, 0.05% — Original Application (Encube Ethicals, Inc.)
FDA approved Desonide Ointment 0.05% as a generic topical corticosteroid for relief of inflammatory and pruritic skin conditions; indicated …
-
FDA approval · 2018-11-05FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved the original application for Fluocinonide Acetonide (a generic topical corticosteroid) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2018-10-16FDA Approved: FLUOCINONIDE — Original Application (Encube Ethicals, Inc.)
FDA approved Fluocinonide under Encube Ethicals, Inc.'s Original Application (ANDA 211410), establishing regulatory approval for this topica…
-
FDA approval · 2018-10-12FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' original application for a generic Betamethasone Dipropionate topical product.
-
FDA approval · 2018-09-28FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)
The FDA approved Viona Pharmaceuticals Inc.'s desoximetasone topical product as an original application, providing a generic version of the …
-
FDA approval · 2018-07-17FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the fluocinonide topical product from Zydus Lifesciences Limited via an Original Application, marking the first generic entry f…
-
FDA approval · 2018-04-23FDA Approved: FLUOCINONIDE — Original Application (NorthStar RxLLC)
FDA approved Fluocinonide through an Original Application (generic) submitted by NorthStar RxLLC.
-
FDA approval · 2018-04-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Xiromed, LLC)
FDA approved the original application for clobetasol propionate (topical) by Xiromed, LLC. It is a potent corticosteroid indicated for corti…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response [Phase 2]
Phase 2 dose-response evaluation of the T.R.U.E. TEST Panel 3.2 allergens in contact dermatitis has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations [Phase 2]
Phase 2 study evaluating bioequivalence of polyvinylpyrrolidone (PVP) formulations used in the T.R.U.E. TEST fragrance mix and thimerosal al…
-
FDA approval · 2018-03-28FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Diprolene (betamethasone dipropionate) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers [Phase 1]
Phase I, single-center trial evaluating the safety and tolerability of PDC-APB in healthy volunteers has been completed, with contact dermat…
-
FDA approval · 2018-02-13FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved Betamethasone Dipropionate as an original application from Encube Ethicals, Inc. (ANDA206389) for topical use in inflammatory d…
-
FDA approval · 2017-11-21FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)
The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LL…
-
FDA approval · 2017-10-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for a generic clobetasol propionate topical product from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2017-10-25FDA Approved: CLOBETASOL PROPIONATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for clobetasol propionate from Macleods Pharmaceuticals Limited.
-
FDA approval · 2017-09-22FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for clobetasol propionate as a generic topical corticosteroid.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis [Phase 1]
Phase 1 clinical trial evaluating the safety and efficacy of BBI-2000 for treating and preventing contact dermatitis has completed.